Discover How Helix is Changing the World of Healthcare
Resources Hub
Technical Briefing 4: Severity of Acute Respiratory Illness
Don’t Forget The Highest Risk: Why Polygenic Risk Scores Alone Aren’t Enough
Genomewide Association Study of Severe Covid-19 with Respiratory Failure
San Diego startup Helix uses pandemic success to push healthcare into the future
Cost-Effectiveness of Population Screening for CDC Tier 1 Conditions
Technical Briefing 3: Average Viral Load Over the Course of the Pandemic
Combining rare and common genetic variants improves population risk stratification for breast cancer
Twist and Shout: Helix is Weaving Population Genomics into the Healthcare Fabric
The Latest Content From Helix
Recent Blog Posts
View All Blog Posts
Blog
Helix awarded "Best Overall Genomics Solution" by MedTech Breakthrough Awards
Blog
Advancing Cancer Care: Helix's New DPYD Testing for Safer Chemotherapy
By MD, FACP, FACMG Cassie Hajek, Medical Director at Helix
Blog
Population Genomics: Personalizing Genetic Breast Cancer Screening
Blog
Unraveling the Power of Germline Clinico-Genomic Data: A Game Changer in Pharma's Drug Development Lifecycle
Recent Press Releases
View All Press ReleasesPress Releases
Helix Launches 23,000-Patient Clinico-Genomic Cohort for Autoimmune Diseases to Advance Drug Discovery and Development
Press Releases
Helix Unveils Groundbreaking Real-World Insights at the ACMG Annual Clinical Genetics Meeting, Driving Clinical Care Forward
Press Releases
Helix Launches World's Largest Clinico-Genomic Cohort of GLP-1 Agonist Treated Patients
Recent Videos
View All Videos
Recent Published Research
View All Published Research1
Published Research
Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60
2
Published Research
Scalable system-wide CYP2C19 pharmacogenomic testing reveals 38% excess incidence of adverse events in metabolizers receiving inappropriate prescriptions
3
Published Research
Population genomic screening leads to improved lipid management in patients with familial hypercholesterolemia
4
Published Research
Underestimated risk of secondary complications in pathogenic and glucose-elevating GCK variant carriers with type 2 diabetes
5
Published Research